A detailed history of Winch Advisory Services, LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Winch Advisory Services, LLC holds 1,000 shares of HRTX stock, worth $1,120. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,000
Previous 1,000 -0.0%
Holding current value
$1,120
Previous $3,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 12, 2020

BUY
$10.89 - $21.47 $10,890 - $21,470
1,000 New
1,000 $15,000
Q1 2020

May 13, 2020

SELL
$10.23 - $24.56 $9,605 - $23,061
-939 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$16.36 - $21.39 $15,362 - $20,085
939 New
939 $17,000
Q2 2018

Aug 13, 2018

SELL
$26.4 - $42.0 $2,640 - $4,200
-100 Closed
0 $0
Q1 2018

May 11, 2018

SELL
$18.43 - $28.8 $3,686 - $5,760
-200 Reduced 66.67%
100 $3,000
Q4 2017

Feb 13, 2018

BUY
$14.8 - $18.85 $4,440 - $5,655
300
300 $5,000

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $133M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Winch Advisory Services, LLC Portfolio

Follow Winch Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winch Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Winch Advisory Services, LLC with notifications on news.